These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 28124759)

  • 1. Human cytomegalovirus (HCMV) UL44 and UL57 specific antibody responses in anti-HCMV-positive patients with systemic sclerosis.
    Marou E; Liaskos C; Simopoulou T; Efthymiou G; Dardiotis E; Katsiari C; Scheper T; Meyer W; Hadjigeorgiou G; Bogdanos DP; Sakkas LI
    Clin Rheumatol; 2017 Apr; 36(4):863-869. PubMed ID: 28124759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased immunoreactivity against human cytomegalovirus UL83 in systemic sclerosis.
    Marou E; Liaskos C; Efthymiou G; Dardiotis E; Daponte A; Scheper T; Meyer W; Hadjigeorgiou G; Bogdanos DP; Sakkas LI
    Clin Exp Rheumatol; 2017; 35 Suppl 106(4):31-34. PubMed ID: 28240591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A study of antigen-specific anti-cytomegalovirus antibody reactivity in patients with systemic sclerosis and concomitant anti-Ro52 antibodies.
    Gkoutzourelas A; Liaskos C; Simopoulou T; Katsiari C; Efthymiou G; Scheper T; Meyer W; Tsirogianni A; Tsigalou C; Dardiotis E; Daoussis D; Sakkas LI; Bogdanos DP
    Rheumatol Int; 2020 Oct; 40(10):1689-1699. PubMed ID: 32681396
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comprehensive analysis of antigen-specific antibody responses against human cytomegalovirus in patients with systemic sclerosis.
    Efthymiou G; Dardiotis E; Liaskos C; Marou E; Scheper T; Meyer W; Daponte A; Daoussis D; Hadjigeorgiou G; Bogdanos DP; Sakkas LI
    Clin Immunol; 2019 Oct; 207():87-96. PubMed ID: 31369821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunoassay with cytomegalovirus early antigens from gene products p52 and CM2 (UL44 and UL57) detects active infection in patients with chronic fatigue syndrome.
    Beqaj SH; Lerner AM; Fitzgerald JT
    J Clin Pathol; 2008 May; 61(5):623-6. PubMed ID: 18037660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IgM serum antibodies to human cytomegalovirus nonstructural gene products p52 and CM2(UL44 and UL57) are uniquely present in a subset of patients with chronic fatigue syndrome.
    Lerner AM; Beqaj SH; Deeter RG; Fitzgerald JT
    In Vivo; 2002; 16(3):153-9. PubMed ID: 12182109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibodies against human cytomegalovirus late protein UL94 in the pathogenesis of scleroderma-like skin lesions in chronic graft-versus-host disease.
    Pastano R; Dell'Agnola C; Bason C; Gigli F; Rabascio C; Puccetti A; Tinazzi E; Cetto G; Peccatori F; Martinelli G; Lunardi C
    Int Immunol; 2012 Sep; 24(9):583-91. PubMed ID: 22773152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibodies to human cytomegalovirus protein UL83 in systemic sclerosis.
    Namboodiri AM; Rocca KM; Kuwana M; Pandey JP
    Clin Exp Rheumatol; 2006; 24(2):176-8. PubMed ID: 16762154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Paradigmatic Interplay between Human Cytomegalovirus and Host Immune System: Possible Involvement of Viral Antigen-Driven CD8+ T Cell Responses in Systemic Sclerosis.
    Arcangeletti MC; Maccari C; Vescovini R; Volpi R; Giuggioli D; Sighinolfi G; De Conto F; Chezzi C; Calderaro A; Ferri C
    Viruses; 2018 Sep; 10(9):. PubMed ID: 30231575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterisation of a human antibody that potentially links cytomegalovirus infection with systemic lupus erythematosus.
    Neo JYJ; Wee SYK; Bonne I; Tay SH; Raida M; Jovanovic V; Fairhurst AM; Lu J; Hanson BJ; MacAry PA
    Sci Rep; 2019 Jul; 9(1):9998. PubMed ID: 31292492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunoglobulin GM genes and IgG antibodies to cytomegalovirus in patients with systemic sclerosis.
    Pandey JP
    Clin Exp Rheumatol; 2004; 22(3 Suppl 33):S35-7. PubMed ID: 15344596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence and clinical associations of anti-Ku antibodies in patients with systemic sclerosis: a European EUSTAR-initiated multi-centre case-control study.
    Rozman B; Cucnik S; Sodin-Semrl S; Czirják L; Varjú C; Distler O; Huscher D; Aringer M; Steiner G; Matucci-Cerinic M; Guiducci S; Stamenkovic B; Stankovic A; Kveder T
    Ann Rheum Dis; 2008 Sep; 67(9):1282-6. PubMed ID: 18063672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating anticentromere CENP-A and CENP-B antibodies in patients with diffuse and limited systemic sclerosis, systemic lupus erythematosus, and rheumatoid arthritis.
    Russo K; Hoch S; Dima C; Varga J; Teodorescu M
    J Rheumatol; 2000 Jan; 27(1):142-8. PubMed ID: 10648030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical correlates of monospecific anti-PM75 and anti-PM100 antibodies in a tri-nation cohort of 1574 systemic sclerosis subjects.
    Wodkowski M; Hudson M; Proudman S; Walker J; Stevens W; Nikpour M; Assassi S; Mayes MD; Tatibouet S; Wang M; ; ; ; Baron M; Fritzler MJ
    Autoimmunity; 2015; 48(8):542-51. PubMed ID: 26334795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differences in autoantibody response to Th/To between systemic sclerosis and other autoimmune diseases.
    Kuwana M; Kimura K; Hirakata M; Kawakami Y; Ikeda Y
    Ann Rheum Dis; 2002 Sep; 61(9):842-6. PubMed ID: 12176814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and serological associations of autoantibodies to the Ku70/Ku80 heterodimer determined by a novel chemiluminescent immunoassay.
    Mahler M; Swart A; Wu J; Szmyrka-Kaczmarek M; Senécal JL; Troyanov Y; Hanly JG; Fritzler MJ
    Lupus; 2016 Jul; 25(8):889-96. PubMed ID: 27252266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-DNA topoisomerase II alpha autoantibodies in Japanese patients with systemic sclerosis.
    Hayakawa I; Hasegawa M; Takehara K; Sato S
    Arch Dermatol Res; 2005 Oct; 297(4):180-3. PubMed ID: 16180014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-CENP-B response in sera of uranium miners exposed to quartz dust and patients with possible development of systemic sclerosis (scleroderma).
    Conrad K; Stahnke G; Liedvogel B; Mehlhorn J; Barth J; Blasum C; Altmeyer P; Sönnichsen N; Frank KH
    J Rheumatol; 1995 Jul; 22(7):1286-94. PubMed ID: 7562760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased serum levels of antibodies against human cytomegalovirus and prevalence of autoantibodies in systemic sclerosis.
    Neidhart M; Kuchen S; Distler O; Brühlmann P; Michel BA; Gay RE; Gay S
    Arthritis Rheum; 1999 Feb; 42(2):389-92. PubMed ID: 10025936
    [No Abstract]   [Full Text] [Related]  

  • 20. Decreased serum level of antibody against human cytomegalovirus in patients with Behçet's disease.
    Lee EB; Kwon YJ; Shin KC; Song YW; Park CG; Hwang ES; Cha CY
    Rheumatol Int; 2005 Jan; 25(1):33-6. PubMed ID: 14600786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.